Corbus Pharmaceuticals Holdings Inc. is a clinical-stage drug development company focused on harnessing the power of cannabinoids to create innovative therapies for rare, chronic, and serious inflammatory diseases. With a strong pipeline and a commitment to scientific excellence, Corbus is poised to make a significant impact in the field of cannabinoid-based medicine.
Notification